8-K - GT Biopharma, Inc. | StockGist

Current Report Details

Event Type

Restatement

Disclosure

Mandatory

Variant

8-K

Items Reported

4.02

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. In connection with the preparation of GT Biopharma

Restatement

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File, formatted in Inline XBRL SIGNATURES Pursuant t

Exhibits Only

Exhibits (1)

8-K